Literature DB >> 18458170

Results of the Predictors of Response to CRT (PROSPECT) trial.

Eugene S Chung1, Angel R Leon, Luigi Tavazzi, Jing-Ping Sun, Petros Nihoyannopoulos, John Merlino, William T Abraham, Stefano Ghio, Christophe Leclercq, Jeroen J Bax, Cheuk-Man Yu, John Gorcsan, Martin St John Sutton, Johan De Sutter, Jaime Murillo.   

Abstract

BACKGROUND: Data from single-center studies suggest that echocardiographic parameters of mechanical dyssynchrony may improve patient selection for cardiac resynchronization therapy (CRT). In a prospective, multicenter setting, the Predictors of Response to CRT (PROSPECT) study tested the performance of these parameters to predict CRT response. METHODS AND
RESULTS: Fifty-three centers in Europe, Hong Kong, and the United States enrolled 498 patients with standard CRT indications (New York Heart Association class III or IV heart failure, left ventricular ejection fraction < or = 35%, QRS > or = 130 ms, stable medical regimen). Twelve echocardiographic parameters of dyssynchrony, based on both conventional and tissue Doppler-based methods, were evaluated after site training in acquisition methods and blinded core laboratory analysis. Indicators of positive CRT response were improved clinical composite score and > or = 15% reduction in left ventricular end-systolic volume at 6 months. Clinical composite score was improved in 69% of 426 patients, whereas left ventricular end-systolic volume decreased > or = 15% in 56% of 286 patients with paired data. The ability of the 12 echocardiographic parameters to predict clinical composite score response varied widely, with sensitivity ranging from 6% to 74% and specificity ranging from 35% to 91%; for predicting left ventricular end-systolic volume response, sensitivity ranged from 9% to 77% and specificity from 31% to 93%. For all the parameters, the area under the receiver-operating characteristics curve for positive clinical or volume response to CRT was < or = 0.62. There was large variability in the analysis of the dyssynchrony parameters.
CONCLUSIONS: Given the modest sensitivity and specificity in this multicenter setting despite training and central analysis, no single echocardiographic measure of dyssynchrony may be recommended to improve patient selection for CRT beyond current guidelines. Efforts aimed at reducing variability arising from technical and interpretative factors may improve the predictive power of these echocardiographic parameters in a broad clinical setting.

Entities:  

Mesh:

Year:  2008        PMID: 18458170     DOI: 10.1161/CIRCULATIONAHA.107.743120

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  465 in total

Review 1.  Cellular electrophysiological abnormalities in dyssynchronous hearts and during CRT.

Authors:  Marc Vanderheyden; Martin Penicka; Jozef Bartunek
Journal:  J Cardiovasc Transl Res       Date:  2011-12-07       Impact factor: 4.132

Review 2.  Functional links between transcription, DNA repair and apoptosis.

Authors:  P Berardi; M Russell; A El-Osta; K Riabowol
Journal:  Cell Mol Life Sci       Date:  2004-09       Impact factor: 9.261

3.  An early proof-of-concept of cardiac resynchronization therapy.

Authors:  Martial G Bourassa; Paul Khairy; Denis Roy
Journal:  World J Cardiol       Date:  2011-12-26

Review 4.  The emerging role of cardiac resynchronization therapy in milder heart failure: are we implanting too late for response?

Authors:  Jason Bradfield; Noel G Boyle; Ravi Mandapati; Kalyanam Shivkumar
Journal:  Curr Heart Fail Rep       Date:  2012-03

5.  Reduced septal glucose metabolism predicts response to cardiac resynchronization therapy.

Authors:  David Birnie; Rob A de Kemp; Anthony S Tang; Terence D Ruddy; Michael H Gollob; Ann Guo; Kathryn Williams; Kerry Thomson; Jean N DaSilva; Rob S Beanlands
Journal:  J Nucl Cardiol       Date:  2011-12-10       Impact factor: 5.952

Review 6.  Cardiac remodeling at the population level--risk factors, screening, and outcomes.

Authors:  Ola Gjesdal; David A Bluemke; Joao A Lima
Journal:  Nat Rev Cardiol       Date:  2011-10-25       Impact factor: 32.419

7.  Can cardiac resynchronization therapy cause harm?

Authors:  John E Sanderson; Cheuk-Man Yu
Journal:  Eur Heart J       Date:  2012-01-31       Impact factor: 29.983

8.  Rationale and design of a randomized trial to assess the safety and efficacy of MultiPoint Pacing (MPP) in cardiac resynchronization therapy: The MPP Trial.

Authors:  Gery Tomassoni; James Baker; Raffaele Corbisiero; Charles Love; David Martin; Robert Sheppard; Seth J Worley; Kwangdeok Lee; Imran Niazi
Journal:  Ann Noninvasive Electrocardiol       Date:  2017-05-18       Impact factor: 1.468

Review 9.  State-of-the-art narrative review: multimodality imaging in electrophysiology and cardiac device therapies.

Authors:  Balint Laczay; Divyang Patel; Richard Grimm; Bo Xu
Journal:  Cardiovasc Diagn Ther       Date:  2021-06

10.  Impact of scar on SPECT assay of left ventricular contraction dyssynchrony.

Authors:  Daniel R Ludwig; Mati Friehling; Erik B Schelbert; David Schwartzman
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-11-09       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.